세계의 국소 창상 치료제 시장 - 시장 규모, 점유율, 동향 분석 보고서 : 최종 용도별, 제품별, 지역별 전망 및 예측(2023-2030년)

The Global Topical Wound Agents Market size is expected to reach $2.5 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

The unique nature of surgical and traumatic wounds drives the demand for diverse wound care agents. Thus, the Surgical & Traumatic segment acquired $170.6 million in 2022. The topical wound agents market responds with specialized products that address specific wound types, promote healing, prevent infections, and improve overall patient outcomes. Technological advancements and adherence to clinical guidelines contribute to the ongoing innovation and development of wound care solutions for surgical and traumatic wounds. Some of the factors impacting the market are rising prevalence of diabetes and road accidents, growing incidence of post-surgical wounds, and high cost of chronic wound treatment.

Diabetes can lead to various problems, such as impaired healing of wounds, lowered immune system activity, and poor circulation. The need for wound care supplies and services grows along with the number of people with diabetes. This demand is driving growth in the market. Diabetes is a significant factor in developing chronic wounds, such as diabetic foot ulcers. With the global increase in the prevalence of diabetes, there is a corresponding rise in the number of individuals at risk of diabetic wounds. According to a WHO report on April 5, 2023, the number of individuals with diabetes expanded from 108 million in 1980 to 422 million in 2014. In low- and middle-income countries, prevalence has risen more rapidly than in high-income countries. Diabetes and diabetic kidney disease caused an estimated 2 million fatalities in 2019. Additionally, surgical procedures frequently result in surgical site infections and wounds, characterized by their increased depth and size compared to other incisions. The discharge of fluids from these surgical wounds necessitates appropriate wound care management; thereby, there is a high requirement for topical wound agents to deal with post-surgical wounds. Post-surgical wounds, including incisions and surgical site infections, necessitate specialized wound care products to promote healing and prevent complications. The market has witnessed a surge in demand for topical wound agents tailored for postoperative care, such as antimicrobial dressings and wounds. Surgical site infections (SSIs) are a significant concern after surgeries, leading to prolonged hospital stays, increased healthcare costs, and patient discomfort. There is a heightened emphasis on wound care products with effective antimicrobial properties to reduce the risk of SSIs and promote faster healing.

Further, the COVID-19 pandemic significantly impacted various sectors within the healthcare industry, including the topical wound agents market. During the initial phases of the pandemic, healthcare resources and attention were diverted towards managing COVID-19 cases, leading to a temporary shift in priorities. Non-urgent medical procedures, including specific wound care treatments, were postponed or delayed, affecting the demand for topical wound agents. Topical wound agents offering antimicrobial or antiseptic properties gained attention due to their role in reducing the risk of wound infections. Therefore, the COVID-19 pandemic moderately impacted the topical wound agents market.

However, chronic wounds take longer to heal, and the prolonged healing process requires continuous monitoring, dressing changes, and ongoing care, leading to increased healthcare resource utilization and associated costs. Chronic wounds often necessitate specialized wound care products such as advanced dressings, bioactive agents, growth factors, and antimicrobial agents. These products are generally more expensive than standard wound care supplies, contributing to higher treatment costs. These services can be expensive and contribute to the overall cost of managing chronic wounds. Hence, the high cost of chronic wound treatment is impeding the market growth of topical wound agents.

End-use Outlook

Based on end-use, the market is categorized into hospitals, clinics, and others. In 2022, the hospitals segment registered the highest revenue share in the market. Hospitals are in high demand for wound treatment due to several factors that require specialized care and expertise. The complexity and diversity of wounds encountered in hospital settings and the need for specialized care, infection control, and emphasis on achieving positive patient outcomes contribute to the high demand for wound treatment and specialized wound care agents within hospitals.

Application Outlook

On the basis of application, the market is segmented into chronic wounds and acute wounds. In 2022, the acute wounds segment attained a noteworthy revenue share in the market. Acute wounds often include surgical incisions resulting from various surgical procedures. The demand for wound care agents tailored for acute wounds continues to grow, driven by the need for practical, evidence-based products that facilitate optimal healing, infection prevention, and patient comfort while managing various types of sudden injuries and post-surgical wounds.

Chronic Wounds Outlook

The chronic wounds segment is further subdivided into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. The pressure ulcers segment held a noteworthy revenue share in the market in 2022. Pressure ulcers are a significant healthcare concern, especially among elderly individuals, immobile patients, or those with limited mobility. The prevalence of pressure ulcers in healthcare settings drives the demand for effective wound management solutions. These are crucial in facilitating wound healing and managing pressure ulcers by promoting tissue repair, reducing infection risk, managing fluids, and alleviating patient discomfort.

Acute Wounds Outlook

The acute wounds segment is further subdivided into surgical & traumatic and burns. In 2022, the burns segment recorded a remarkable revenue share in the market. Burn injuries, particularly severe burns, create a substantial demand for specialized topical wound care products that cater to the unique needs of burn patients. The market responds by offering diverse wound care agents to address the complexities associated with burn injuries, focusing on infection prevention, pain management, wound healing promotion, and overall patient comfort and recovery.

Product Outlook

Based on product, the market is divided into creams, gels, sprays, and others. In 2022, the creams segment garnered the highest revenue share in the market. Patients and healthcare providers favor creams due to their simplicity of application and user-friendliness. Their smooth consistency allows for even coverage over the wound area, enabling non-restrictive application. Due to these factors, creams are prominent in the market. Catering to a wide range of wound care needs and offering a user-friendly option for healthcare professionals and patients involved in wound management.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed the maximum revenue share in the market in 2022. The region boasts a well-established healthcare infrastructure with sophisticated facilities, advanced technologies, and access to innovative wound care solutions. This infrastructure allows for the adoption of cutting-edge wound care agents and therapies. Furthermore, North America has a high prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions. These diseases often lead to chronic wounds, driving the demand for topical wound agents and products.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Viatris, Inc. (Mylan N.V.), AstraZeneca PLC, Coloplast Group, Novartis AG, Pfizer Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), and ConvaTec Group PLC

Scope of the Study

Market Segments covered in the Report:

By End-use

• Hospitals
• Clinics
• Others

By Application

• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others
• Acute Wounds
  • Surgical & Traumatic
  • Burns

By Product

• Creams
• Gels
• Sprays
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Smith & Nephew PLC
• Teva Pharmaceutical Industries Ltd.
• Molnlycke Health Care AB
• Viatris, Inc. (Mylan N.V.)
• AstraZeneca PLC
• Coloplast Group
• Novartis AG
• Pfizer Inc.
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• ConvaTec Group PLC

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Topical Wound Agents Market, by End-use
  • 1.4.2 Global Topical Wound Agents Market, by Application
  • 1.4.3 Global Topical Wound Agents Market, by Product
  • 1.4.4 Global Topical Wound Agents Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Topical Wound Agents Market by End-use

• 4.1 Global Hospitals Market by Region
• 4.2 Global Clinics Market by Region
• 4.3 Global Others Market by Region

Chapter 5. Global Topical Wound Agents Market by Application

• 5.1 Global Chronic Wounds Market by Region
• 5.2 Global Topical Wound Agents Market by Chronic Wounds Type
  • 5.2.1 Global Diabetic Foot Ulcers Market by Region
  • 5.2.2 Global Pressure Ulcers Market by Region
  • 5.2.3 Global Venous Leg Ulcers Market by Region
  • 5.2.4 Global Others Market by Region
• 5.3 Global Acute Wounds Market by Region
• 5.4 Global Topical Wound Agents Market by Acute Wounds Type
  • 5.4.1 Global Surgical & Traumatic Market by Region
  • 5.4.2 Global Burns Market by Region

Chapter 6. Global Topical Wound Agents Market by Product

• 6.1 Global Creams Market by Region
• 6.2 Global Gels Market by Region
• 6.3 Global Sprays Market by Region
• 6.4 Global Others Market by Region

Chapter 7. Global Topical Wound Agents Market by Region

• 7.1 North America Topical Wound Agents Market
  • 7.1.1 North America Topical Wound Agents Market by End-use
    • 7.1.1.1 North America Hospitals Market by Country
    • 7.1.1.2 North America Clinics Market by Country
    • 7.1.1.3 North America Others Market by Country
  • 7.1.2 North America Topical Wound Agents Market by Application
    • 7.1.2.1 North America Chronic Wounds Market by Region
    • 7.1.2.2 North America Topical Wound Agents Market by Chronic Wounds Type
      • 7.1.2.2.1 North America Diabetic Foot Ulcers Market by Country
      • 7.1.2.2.2 North America Pressure Ulcers Market by Country
      • 7.1.2.2.3 North America Venous Leg Ulcers Market by Country
      • 7.1.2.2.4 North America Others Market by Country
    • 7.1.2.3 North America Acute Wounds Market by Region
    • 7.1.2.4 North America Topical Wound Agents Market by Acute Wounds Type
      • 7.1.2.4.1 North America Surgical & Traumatic Market by Country
      • 7.1.2.4.2 North America Burns Market by Country
  • 7.1.3 North America Topical Wound Agents Market by Product
    • 7.1.3.1 North America Creams Market by Country
    • 7.1.3.2 North America Gels Market by Country
    • 7.1.3.3 North America Sprays Market by Country
    • 7.1.3.4 North America Others Market by Country
  • 7.1.4 North America Topical Wound Agents Market by Country
    • 7.1.4.1 US Topical Wound Agents Market
      • 7.1.4.1.1 US Topical Wound Agents Market by End-use
      • 7.1.4.1.2 US Topical Wound Agents Market by Application
      • 7.1.4.1.3 US Topical Wound Agents Market by Product
    • 7.1.4.2 Canada Topical Wound Agents Market
      • 7.1.4.2.1 Canada Topical Wound Agents Market by End-use
      • 7.1.4.2.2 Canada Topical Wound Agents Market by Application
      • 7.1.4.2.3 Canada Topical Wound Agents Market by Product
    • 7.1.4.3 Mexico Topical Wound Agents Market
      • 7.1.4.3.1 Mexico Topical Wound Agents Market by End-use
      • 7.1.4.3.2 Mexico Topical Wound Agents Market by Application
      • 7.1.4.3.3 Mexico Topical Wound Agents Market by Product
    • 7.1.4.4 Rest of North America Topical Wound Agents Market
      • 7.1.4.4.1 Rest of North America Topical Wound Agents Market by End-use
      • 7.1.4.4.2 Rest of North America Topical Wound Agents Market by Application
      • 7.1.4.4.3 Rest of North America Topical Wound Agents Market by Product
• 7.2 Europe Topical Wound Agents Market
  • 7.2.1 Europe Topical Wound Agents Market by End-use
    • 7.2.1.1 Europe Hospitals Market by Country
    • 7.2.1.2 Europe Clinics Market by Country
    • 7.2.1.3 Europe Others Market by Country
  • 7.2.2 Europe Topical Wound Agents Market by Application
    • 7.2.2.1 Europe Chronic Wounds Market by Country
    • 7.2.2.2 Europe Topical Wound Agents Market by Chronic Wounds Type
      • 7.2.2.2.1 Europe Diabetic Foot Ulcers Market by Country
      • 7.2.2.2.2 Europe Pressure Ulcers Market by Country
      • 7.2.2.2.3 Europe Venous Leg Ulcers Market by Country
      • 7.2.2.2.4 Europe Others Market by Country
    • 7.2.2.3 Europe Acute Wounds Market by Country
    • 7.2.2.4 Europe Topical Wound Agents Market by Acute Wounds Type
      • 7.2.2.4.1 Europe Surgical & Traumatic Market by Country
      • 7.2.2.4.2 Europe Burns Market by Country
  • 7.2.3 Europe Topical Wound Agents Market by Product
    • 7.2.3.1 Europe Creams Market by Country
    • 7.2.3.2 Europe Gels Market by Country
    • 7.2.3.3 Europe Sprays Market by Country
    • 7.2.3.4 Europe Others Market by Country
  • 7.2.4 Europe Topical Wound Agents Market by Country
    • 7.2.4.1 Germany Topical Wound Agents Market
      • 7.2.4.1.1 Germany Topical Wound Agents Market by End-use
      • 7.2.4.1.2 Germany Topical Wound Agents Market by Application
      • 7.2.4.1.3 Germany Topical Wound Agents Market by Product
    • 7.2.4.2 UK Topical Wound Agents Market
      • 7.2.4.2.1 UK Topical Wound Agents Market by End-use
      • 7.2.4.2.2 UK Topical Wound Agents Market by Application
      • 7.2.4.2.3 UK Topical Wound Agents Market by Product
    • 7.2.4.3 France Topical Wound Agents Market
      • 7.2.4.3.1 France Topical Wound Agents Market by End-use
      • 7.2.4.3.2 France Topical Wound Agents Market by Application
      • 7.2.4.3.3 France Topical Wound Agents Market by Product
    • 7.2.4.4 Russia Topical Wound Agents Market
      • 7.2.4.4.1 Russia Topical Wound Agents Market by End-use
      • 7.2.4.4.2 Russia Topical Wound Agents Market by Application
      • 7.2.4.4.3 Russia Topical Wound Agents Market by Product
    • 7.2.4.5 Spain Topical Wound Agents Market
      • 7.2.4.5.1 Spain Topical Wound Agents Market by End-use
      • 7.2.4.5.2 Spain Topical Wound Agents Market by Application
      • 7.2.4.5.3 Spain Topical Wound Agents Market by Product
    • 7.2.4.6 Italy Topical Wound Agents Market
      • 7.2.4.6.1 Italy Topical Wound Agents Market by End-use
      • 7.2.4.6.2 Italy Topical Wound Agents Market by Application
      • 7.2.4.6.3 Italy Topical Wound Agents Market by Product
    • 7.2.4.7 Rest of Europe Topical Wound Agents Market
      • 7.2.4.7.1 Rest of Europe Topical Wound Agents Market by End-use
      • 7.2.4.7.2 Rest of Europe Topical Wound Agents Market by Application
      • 7.2.4.7.3 Rest of Europe Topical Wound Agents Market by Product
• 7.3 Asia Pacific Topical Wound Agents Market
  • 7.3.1 Asia Pacific Topical Wound Agents Market by End-use
    • 7.3.1.1 Asia Pacific Hospitals Market by Country
    • 7.3.1.2 Asia Pacific Clinics Market by Country
    • 7.3.1.3 Asia Pacific Others Market by Country
  • 7.3.2 Asia Pacific Topical Wound Agents Market by Application
    • 7.3.2.1 Asia Pacific Chronic Wounds Market by Country
    • 7.3.2.2 Asia Pacific Topical Wound Agents Market by Chronic Wounds Type
      • 7.3.2.2.1 Asia Pacific Diabetic Foot Ulcers Market by Country
      • 7.3.2.2.2 Asia Pacific Pressure Ulcers Market by Country
      • 7.3.2.2.3 Asia Pacific Venous Leg Ulcers Market by Country
      • 7.3.2.2.4 Asia Pacific Others Market by Country
    • 7.3.2.3 Asia Pacific Acute Wounds Market by Country
    • 7.3.2.4 Asia Pacific Topical Wound Agents Market by Acute Wounds Type
      • 7.3.2.4.1 Asia Pacific Surgical & Traumatic Market by Country
      • 7.3.2.4.2 Asia Pacific Burns Market by Country
  • 7.3.3 Asia Pacific Topical Wound Agents Market by Product
    • 7.3.3.1 Asia Pacific Creams Market by Country
    • 7.3.3.2 Asia Pacific Gels Market by Country
    • 7.3.3.3 Asia Pacific Sprays Market by Country
    • 7.3.3.4 Asia Pacific Others Market by Country
  • 7.3.4 Asia Pacific Topical Wound Agents Market by Country
    • 7.3.4.1 China Topical Wound Agents Market
      • 7.3.4.1.1 China Topical Wound Agents Market by End-use
      • 7.3.4.1.2 China Topical Wound Agents Market by Application
      • 7.3.4.1.3 China Topical Wound Agents Market by Product
    • 7.3.4.2 Japan Topical Wound Agents Market
      • 7.3.4.2.1 Japan Topical Wound Agents Market by End-use
      • 7.3.4.2.2 Japan Topical Wound Agents Market by Application
      • 7.3.4.2.3 Japan Topical Wound Agents Market by Product
    • 7.3.4.3 India Topical Wound Agents Market
      • 7.3.4.3.1 India Topical Wound Agents Market by End-use
      • 7.3.4.3.2 India Topical Wound Agents Market by Application
      • 7.3.4.3.3 India Topical Wound Agents Market by Product
    • 7.3.4.4 South Korea Topical Wound Agents Market
      • 7.3.4.4.1 South Korea Topical Wound Agents Market by End-use
      • 7.3.4.4.2 South Korea Topical Wound Agents Market by Application
      • 7.3.4.4.3 South Korea Topical Wound Agents Market by Product
    • 7.3.4.5 Singapore Topical Wound Agents Market
      • 7.3.4.5.1 Singapore Topical Wound Agents Market by End-use
      • 7.3.4.5.2 Singapore Topical Wound Agents Market by Application
      • 7.3.4.5.3 Singapore Topical Wound Agents Market by Product
    • 7.3.4.6 Malaysia Topical Wound Agents Market
      • 7.3.4.6.1 Malaysia Topical Wound Agents Market by End-use
      • 7.3.4.6.2 Malaysia Topical Wound Agents Market by Application
      • 7.3.4.6.3 Malaysia Topical Wound Agents Market by Product
    • 7.3.4.7 Rest of Asia Pacific Topical Wound Agents Market
      • 7.3.4.7.1 Rest of Asia Pacific Topical Wound Agents Market by End-use
      • 7.3.4.7.2 Rest of Asia Pacific Topical Wound Agents Market by Application
      • 7.3.4.7.3 Rest of Asia Pacific Topical Wound Agents Market by Product
• 7.4 LAMEA Topical Wound Agents Market
  • 7.4.1 LAMEA Topical Wound Agents Market by End-use
    • 7.4.1.1 LAMEA Hospitals Market by Country
    • 7.4.1.2 LAMEA Clinics Market by Country
    • 7.4.1.3 LAMEA Others Market by Country
  • 7.4.2 LAMEA Topical Wound Agents Market by Application
    • 7.4.2.1 LAMEA Chronic Wounds Market by Country
    • 7.4.2.2 LAMEA Topical Wound Agents Market by Chronic Wounds Type
      • 7.4.2.2.1 LAMEA Diabetic Foot Ulcers Market by Country
      • 7.4.2.2.2 LAMEA Pressure Ulcers Market by Country
      • 7.4.2.2.3 LAMEA Venous Leg Ulcers Market by Country
      • 7.4.2.2.4 LAMEA Others Market by Country
    • 7.4.2.3 LAMEA Acute Wounds Market by Country
    • 7.4.2.4 LAMEA Topical Wound Agents Market by Acute Wounds Type
      • 7.4.2.4.1 LAMEA Surgical & Traumatic Market by Country
      • 7.4.2.4.2 LAMEA Burns Market by Country
  • 7.4.3 LAMEA Topical Wound Agents Market by Product
    • 7.4.3.1 LAMEA Creams Market by Country
    • 7.4.3.2 LAMEA Gels Market by Country
    • 7.4.3.3 LAMEA Sprays Market by Country
    • 7.4.3.4 LAMEA Others Market by Country
  • 7.4.4 LAMEA Topical Wound Agents Market by Country
    • 7.4.4.1 Brazil Topical Wound Agents Market
      • 7.4.4.1.1 Brazil Topical Wound Agents Market by End-use
      • 7.4.4.1.2 Brazil Topical Wound Agents Market by Application
      • 7.4.4.1.3 Brazil Topical Wound Agents Market by Product
    • 7.4.4.2 Argentina Topical Wound Agents Market
      • 7.4.4.2.1 Argentina Topical Wound Agents Market by End-use
      • 7.4.4.2.2 Argentina Topical Wound Agents Market by Application
      • 7.4.4.2.3 Argentina Topical Wound Agents Market by Product
    • 7.4.4.3 UAE Topical Wound Agents Market
      • 7.4.4.3.1 UAE Topical Wound Agents Market by End-use
      • 7.4.4.3.2 UAE Topical Wound Agents Market by Application
      • 7.4.4.3.3 UAE Topical Wound Agents Market by Product
    • 7.4.4.4 Saudi Arabia Topical Wound Agents Market
      • 7.4.4.4.1 Saudi Arabia Topical Wound Agents Market by End-use
      • 7.4.4.4.2 Saudi Arabia Topical Wound Agents Market by Application
      • 7.4.4.4.3 Saudi Arabia Topical Wound Agents Market by Product
    • 7.4.4.5 South Africa Topical Wound Agents Market
      • 7.4.4.5.1 South Africa Topical Wound Agents Market by End-use
      • 7.4.4.5.2 South Africa Topical Wound Agents Market by Application
      • 7.4.4.5.3 South Africa Topical Wound Agents Market by Product
    • 7.4.4.6 Nigeria Topical Wound Agents Market
      • 7.4.4.6.1 Nigeria Topical Wound Agents Market by End-use
      • 7.4.4.6.2 Nigeria Topical Wound Agents Market by Application
      • 7.4.4.6.3 Nigeria Topical Wound Agents Market by Product
    • 7.4.4.7 Rest of LAMEA Topical Wound Agents Market
      • 7.4.4.7.1 Rest of LAMEA Topical Wound Agents Market by End-use
      • 7.4.4.7.2 Rest of LAMEA Topical Wound Agents Market by Application
      • 7.4.4.7.3 Rest of LAMEA Topical Wound Agents Market by Product

Chapter 8. Company Profiles

• 8.1 Smith & Nephew PLC
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Regional and Segmental Analysis
  • 8.1.4 Research & Development Expense
  • 8.1.5 SWOT Analysis
• 8.2 Teva Pharmaceutical Industries Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Regional Analysis
  • 8.2.4 Research & Development Expenses
  • 8.2.5 SWOT Analysis
• 8.3 Molnlycke Health Care AB
  • 8.3.1 Company Overview
  • 8.3.2 SWOT Analysis
• 8.4 Viatris, Inc. (Mylan N.V.)
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Segmental Analysis
  • 8.4.4 Research & Development Expense
  • 8.4.5 SWOT Analysis
• 8.5 AstraZeneca PLC
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Regional Analysis
  • 8.5.4 Research & Development Expenses
  • 8.5.5 SWOT Analysis
• 8.6 Coloplast Group
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Segmental and Regional Analysis
  • 8.6.4 Research & Development Expense
  • 8.6.5 SWOT Analysis
• 8.7 Novartis AG
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental and Regional Analysis
  • 8.7.4 Research & Development Expense
  • 8.7.5 SWOT Analysis
• 8.8 Pfizer, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Financial Analysis
  • 8.8.3 Regional & Segmental Analysis
  • 8.8.4 Research & Development Expense
  • 8.8.5 Recent strategies and developments:
    • 8.8.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8.6 SWOT Analysis
• 8.9 Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • 8.9.1 Company Overview
  • 8.9.2 Financial Analysis
  • 8.9.3 Segmental &Regional Analysis
  • 8.9.4 Research & Development Expenses
  • 8.9.5 Recent strategies and developments:
    • 8.9.5.1 Partnerships, Collaborations, and Agreements:
  • 8.9.6 SWOT Analysis
• 8.10. ConvaTec Group PLC
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 SWOT Analysis

Chapter 9. Winning Imperatives of Topical Wound Agents Market